San Diego-primarily based Viking Therapeutics marked alone as a serious competitor during the weight loss drug market place in February after revealing promising facts from a mid-phase demo of experimental drug VK2735, which instructed it rivaled—and outperformed—Novo and Lilly drugs when given being a weekly injection As well as in March the c